Literature DB >> 33532137

Pathogenesis and Management in Cerebrovenous Outflow Disorders.

Chaobo Bai1,2,3, Zhongao Wang1,2,3, Christopher Stone4, Da Zhou1,2,3, Jiayue Ding1,2,3, Yuchuan Ding3,4, Xunming Ji2,3,5, Ran Meng1,2,3.   

Abstract

In keeping with its status as one of the major causes of disability and mortality worldwide, brain damage induced by cerebral arterial disease has been the subject of several decades of scientific investigation, which has resulted in a vastly improved understanding of its pathogenesis. Brain injury mediated by venous etiologies, however, such as cerebral, jugular, and vertebral venous outflow disturbance, have been largely ignored by clinicians. Unfortunately, this inattention is not proportional to the severity of cerebral venous diseases, as the impact they exact on the quality of life of affected patients may be no less than that of arterial diseases. This is evident in disease sequelae such as cerebral venous thrombosis (CVT)-mediated visual impairment, epilepsy, and intracranial hypertension; and the long-term unbearable head noise, tinnitus, headache, dizziness, sleeping disorder, and even severe intracranial hypertension induced by non-thrombotic cerebral venous sinus (CVS) stenosis and/or internal jugular venous (IJV) stenosis. In addition, the vertebral venous system (VVS), a large volume, valveless vascular network that stretches from the brain to the pelvis, provides a conduit for diffuse transmission of tumors, infections, or emboli, with potentially devastating clinical consequences. Moreover, the lack of specific features and focal neurologic signs seen with arterial etiologies render cerebral venous disease prone to both to misdiagnoses and missed diagnoses. It is therefore imperative that awareness be raised, and that as comprehensive an understanding as possible of these issues be cultivated. In this review, we attempt to facilitate these goals by systematically summarizing recent advances in the diagnosis and treatment of these entities, including CVT, CVS stenosis, and IJV stenosis, with the aim of providing a valid, practical reference for clinicians. copyright:
© 2021 Bai et al.

Entities:  

Keywords:  cerebral venous sinus stenosis; cerebral venous thrombosis; diagnosis; internal jugular vein stenosis; treatment

Year:  2021        PMID: 33532137      PMCID: PMC7801276          DOI: 10.14336/AD.2020.0404

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  5 in total

1.  Effects of low molecular weight heparin combined with hyperbaric oxygen on neurologic function and coagulation factors in patients with intracranial venous thrombosis.

Authors:  Bo-Feng Liu; Xiao-Hui Liu; Xiao-Hui Dong; Ning Ma; Hui-Ping Zhang; Li-Li Jiang; Yan-Qing Liu
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Nonthrombotic internal jugular venous stenosis may facilitate cerebral venous thrombosis.

Authors:  Xiaoqin Wu; Jingyuan Ya; Da Zhou; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  CNS Neurosci Ther       Date:  2021-08-16       Impact factor: 5.243

Review 3.  Pathogeneses and Imaging Features of Cerebral White Matter Lesions of Vascular Origins.

Authors:  Xiaoqin Wu; Jingyuan Ya; Da Zhou; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

4.  Differentiation between anatomical slenderness and acquired stenosis of the internal jugular veins.

Authors:  Mengqi Wang; Xiaoqin Wu; Duo Lan; Da Zhou; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  CNS Neurosci Ther       Date:  2022-08-02       Impact factor: 7.035

Review 5.  Animal Models of Epilepsy: A Phenotype-oriented Review.

Authors:  Yilin Wang; Penghu Wei; Feng Yan; Yumin Luo; Guoguang Zhao
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.